THL Credit Reports First Quarter 2017 Financial Results and Declares a Dividend of $0.27 Per Share
May 04, 2017 20:07 pm UTC| Business
BOSTON, May 04, 2017 -- THL Credit, Inc. (NASDAQ:TCRD) (“THL Credit” or the “Company”), a direct lender to lower middle market companies, announced today financial results for its first fiscal quarter ended March 31,...
Fluidigm Announces First Quarter Financial Results
May 04, 2017 20:07 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 04, 2017 -- Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the first quarter ended March 31, 2017. Total revenue for the quarter was $25.5 million, a...
THL Credit Reports First Quarter 2017 Financial Results and Declares a Dividend of $0.27 Per Share
May 04, 2017 20:07 pm UTC| Business
BOSTON, May 04, 2017 -- THL Credit, Inc. (NASDAQ:TCRD) (“THL Credit” or the “Company”), a direct lender to lower middle market companies, announced today financial results for its first fiscal quarter ended March 31,...
THL Credit Reports First Quarter 2017 Financial Results and Declares a Dividend of $0.27 Per Share
May 04, 2017 20:07 pm UTC| Business
BOSTON, May 04, 2017 -- THL Credit, Inc. (NASDAQ:TCRD) (“THL Credit” or the “Company”), a direct lender to lower middle market companies, announced today financial results for its first fiscal quarter ended March 31,...
Five Prime Announces First Quarter 2017 Results and Provides Business Update
May 04, 2017 20:07 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 04, 2017 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...
Five Prime Announces First Quarter 2017 Results and Provides Business Update
May 04, 2017 20:07 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 04, 2017 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...
Five Prime Announces First Quarter 2017 Results and Provides Business Update
May 04, 2017 20:07 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 04, 2017 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...